Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment

Detalles Bibliográficos
Autores principales: Yalcin, Ata Nevzat, Yalcin, Arzu Didem, Celik, Betul, Kose, Sukran, Cekin, Ayhan, Seyman, Derya, Gumuslu, Saadet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2015
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405991/
http://dx.doi.org/10.1186/1939-4551-8-S1-A8
_version_ 1782367701154398208
author Yalcin, Ata Nevzat
Yalcin, Arzu Didem
Celik, Betul
Kose, Sukran
Cekin, Ayhan
Seyman, Derya
Gumuslu, Saadet
author_facet Yalcin, Ata Nevzat
Yalcin, Arzu Didem
Celik, Betul
Kose, Sukran
Cekin, Ayhan
Seyman, Derya
Gumuslu, Saadet
author_sort Yalcin, Ata Nevzat
collection PubMed
description
format Online
Article
Text
id pubmed-4405991
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-44059912015-04-28 Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment Yalcin, Ata Nevzat Yalcin, Arzu Didem Celik, Betul Kose, Sukran Cekin, Ayhan Seyman, Derya Gumuslu, Saadet World Allergy Organ J Meeting Abstract World Allergy Organization 2015-04-08 /pmc/articles/PMC4405991/ http://dx.doi.org/10.1186/1939-4551-8-S1-A8 Text en Copyright © 2015 Yalcin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Yalcin, Ata Nevzat
Yalcin, Arzu Didem
Celik, Betul
Kose, Sukran
Cekin, Ayhan
Seyman, Derya
Gumuslu, Saadet
Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
title Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
title_full Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
title_fullStr Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
title_full_unstemmed Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
title_short Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
title_sort circulating apo 2l levels decreased in hepatitis c with the pegilated interferon-2 alpha treatment
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405991/
http://dx.doi.org/10.1186/1939-4551-8-S1-A8
work_keys_str_mv AT yalcinatanevzat circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment
AT yalcinarzudidem circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment
AT celikbetul circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment
AT kosesukran circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment
AT cekinayhan circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment
AT seymanderya circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment
AT gumuslusaadet circulatingapo2llevelsdecreasedinhepatitiscwiththepegilatedinterferon2alphatreatment

Ejemplares similares